Confluence Wealth Services’s Quest Diagnostics DGX Stock Holding History
Bought
Maintained
Sold
Other funds holding DGX
AIM
EB
CPC
AIM
AAMU
AAIS
BCAM
Confluence Wealth Services's DGX Position: Q2 2026 in Review
Confluence Wealth Services opened a new position in Quest Diagnostics (DGX) in Q2 2026: 1,191 shares worth $252K. The stake represents 0.01% of the portfolio and ranks #428 among its holdings. This is a return to the name: Confluence Wealth Services previously reported a position in DGX as recently as Q4 2021.
Confluence Wealth Services first reported a position in DGX in Q4 2021 and has held it in 2 quarters since. 264 funds tracked by Wall St. Rank hold DGX as of Q2 2026.
- Confluence Wealth Services held 1,191 shares of Quest Diagnostics worth $252K as of Q2 2026.
- Quest Diagnostics was a new Confluence Wealth Services position in Q2 2026.
- Quest Diagnostics made up 0.01% of Confluence Wealth Services's portfolio in Q2 2026, its #428 holding.
- Confluence Wealth Services first reported a position in Quest Diagnostics in Q4 2021 and has held it in 2 quarters since.
- 264 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.
Based on Confluence Wealth Services's 13F filing for Q2 2026, filed 22 Jul 2026.